Limited coverage criteria – sumatriptan

Last updated on April 15, 2025

 

Return to Special Authority drug list

Generic name

sumatriptan

Form

6 mg/0.5 mL vial
6 mg/0.5 mL pen injector

Special Authority criteria

Approval period

Nausea and vomiting that prevents swallowing of oral preparations OR where oral absorption is not practical Indefinite

Practitioner exemptions

  • Practitioners specialized in neurology are not required to submit a Special Authority request for coverage

Special notes

  • None

Special Authority request form(s)